CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (USD $)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash Flow From Operating Activities:
Net income (loss)	$ 9,144	$ (1,671)
Adjustments to reconcile net loss applicable to common shares to net cash used in operating activities:
Gain (loss) on sale of land	48	(5,160)
Gain on sale of income-producing properties	(24,265)	(5,091)
Depreciation and Amortization.	10,761	11,236
Provision on impairment of notes receivable and real estate asset	0	0
Amortization of deferred borrowing costs	3,383	2,864
(Earnings) losses from unconsolidated subsidiaries and investees	(23)	8
(Increase) decrease in assets:
Accrued interest receivable	296	(6,370)
Other Assets	0	0
Prepaid expense	(1,008)	5
Escrow	10,227	3,991
Earnest money	525	235
Rent receivables	2,924	(504)
Related party receivables.	(7,125)	0
Increase (decrease) in liabilities:
Accrued interest payable	(2,186)	(6,790)
Related party-payables	(10,057)	18,811
Other liabilities	(8,081)	(22,223)
Net cash used in operating activities	(15,437)	(10,659)
Cash Flow From Investing Activities:
Proceeds from notes receivable	0	11,993
Originations or advances on notes receivable	(343)	(6,000)
Acquisition of land held for development	(7)	(18,948)
Acquisition of income-producing properties	0	0
Proceeds from sale of income-producing properties	75,874	37,038
Proceeds from sale of land	2,537	20,667
Proceeds from sale of investment in unconsolidated real estate entities	0	0
Proceeds from sale of investments	0	132
Investment in unconsolidated real estate entities	(278)	585
Improvement of land held for development	(290)	(164)
Improvement of income-producing properties	(3,333)	(725)
Acquisition of non-controlling interest		(69)
Sales of controlling interest	54	113
Construction and development of new properties	(179)	(4,185)
Net cash provided by investing activities	74,035	40,437
Cash Flow From Financing Activities:
Proceeds from notes payable	136,172	138,675
Recurring amortization of principal on notes payable	(7,504)	(14,381)
Payments on maturing notes payable	(193,031)	(153,164)
Deferred financing costs	(1,296)	(2,815)
Contributions (distributions) to non-controlling interests	(14)	(8)
Common stock issuance	0	0
Preferred stock dividends - Series C	(105)	(106)
Preferred stock dividends - Series D	(446)	(448)
Net cash used in financing activities	(66,224)	(32,247)
Net decrease in cash and cash equivalents	(7,626)	(2,469)
Cash and cash equivalents, beginning of period	16,620	19,991
Cash and cash equivalents, end of period	8,994	17,522
Supplemental disclosures of cash flow information:
Cash paid for interest	20,125	23,076
Schedule of noncash investing and financing activities:
Notes receivable received from related party	0	6,000
Related party payable/receivable for ARL cost basis sales adjustment	0	10,445
Acquisition of land for ARL cost basis sales adjustment	$ 0	$ (10,445)